Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers.
Néstor Vázquez-AgraAna-Teresa Marques-AfonsoAnton Cruces-SandeEstefania Mendez-AlvarezRamon Soto-OteroJose-Enrique Lopez-PazAntonio Pose-ReinoÁlvaro Hermida-AmeijeirasPublished in: Antioxidants (Basel, Switzerland) (2023)
As in other fields, chronotherapy applied to arterial hypertension (AHT) may have implications on oxidative stress. We compared the levels of some redox markers between hypertensive patients with morning and bedtime use of renin-angiotensin-aldosterone system (RAAS) blockers. This was an observational study that included patients older than 18 years with a diagnosis of essential AHT. Blood pressure (BP) figures were measured using twenty-four-hour ambulatory BP monitoring (24-h ABPM). Lipid peroxidation and protein oxidation were assessed using the thiobarbituric acid reactive substances (TBARS) and reduced thiols assays. We recruited 70 patients with a median age of 54 years, of whom 38 (54%) were women. In hypertensive patients with bedtime use of RAAS blockers, reduced thiol levels showed a positive correlation with nocturnal diastolic BP decrease. TBARS levels were associated with bedtime use of RAAS blockers in dipper and non-dipper hypertensive patients. In non-dipper patients, bedtime use of RAAS blockers was also associated with a decrease in nocturnal diastolic BP. Chronotherapy applied to bedtime use of some BP-lowering drugs in hypertensive patients may be linked to a better redox profile.
Keyphrases
- blood pressure
- hypertensive patients
- angiotensin converting enzyme
- angiotensin ii
- heart rate
- end stage renal disease
- oxidative stress
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- blood glucose
- pregnant women
- induced apoptosis
- dna damage
- peritoneal dialysis
- arterial hypertension
- weight loss
- adipose tissue
- heart failure
- type diabetes
- obstructive sleep apnea
- high throughput
- small molecule
- patient reported outcomes
- metabolic syndrome
- physical activity
- depressive symptoms
- skeletal muscle
- signaling pathway
- heat stress
- protein protein
- fatty acid